Literature DB >> 28373582

Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic Cells.

Tomohiro Watanabe1,2, Kouhei Yamashita3, Yasuyuki Arai3, Kosuke Minaga4, Ken Kamata4, Tomoyuki Nagai4, Yoriaki Komeda4, Mamoru Takenaka4, Satoru Hagiwara4, Hiroshi Ida4, Toshiharu Sakurai4, Naoshi Nishida4, Warren Strober2, Masatoshi Kudo4.   

Abstract

In previous studies, we found that human IgG4-related autoimmune pancreatitis (AIP) and murine AIP are driven by activation of plasmacytoid dendritic cells (pDCs) producing IFN-α. In the present studies we examined additional roles of pDC-related mechanisms in AIP pathogenesis, particularly those responsible for induction of fibrosis. We found that in murine AIP (MRL/Mp mice treated with polyinosinic-polycytidylic acid) not only the pancreatic infiltration of immune cells but also the development of fibrosis were markedly reduced by the depletion of pDCs or blockade of type I IFN signaling; moreover, such treatment was accompanied by a marked reduction of pancreatic expression of IL-33. Conversely, polyinosinic-polycytidylic acid-induced inflamed pancreatic tissue in murine AIP exhibited increased expression of type I IFNs and IL-33 (and downstream IL-33 cytokines such as IL-13 and TGF-β1). pDCs stimulated by type I IFN were the source of the IL-33 because purified populations of these cells isolated from the inflamed pancreas produced a large amount of IL-33 upon activation by TLR9 ligands, and such production was abrogated by the neutralization of type I IFN. The role of IL-33 in murine AIP pathogenesis was surprisingly important because blockade of IL-33 signaling by anti-ST2 Ab attenuated both pancreatic inflammation and accompanying fibrosis. Finally, whereas patients with both conventional pancreatitis and IgG4-related AIP exhibited increased numbers of acinar cells expressing IL-33, only the latter also exhibited pDCs producing this cytokine. These data thus suggest that pDCs producing IFN-α and IL-33 play a pivotal role in the chronic fibro-inflammatory responses underlying murine AIP and human IgG4-related AIP.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28373582     DOI: 10.4049/jimmunol.1700060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.

Authors:  Tomohiro Watanabe; Kosuke Minaga; Ken Kamata; Toshiharu Sakurai; Yoriaki Komeda; Tomoyuki Nagai; Atsushi Kitani; Masaki Tajima; Ivan J Fuss; Masatoshi Kudo; Warren Strober
Journal:  Int Immunol       Date:  2019-09-18       Impact factor: 4.823

Review 2.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

3.  Autoimmune Pancreatitis Mouse Model.

Authors:  Ken Kamata; Tomohiro Watanabe; Kosuke Minaga; Warren Strober; Masatoshi Kudo
Journal:  Curr Protoc Immunol       Date:  2018-02-21

4.  Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone.

Authors:  K Kamata; T Watanabe; K Minaga; A Hara; I Sekai; Y Otsuka; T Yoshikawa; A-M Park; M Kudo
Journal:  Clin Exp Immunol       Date:  2020-09-21       Impact factor: 4.330

5.  Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis.

Authors:  Kosuke Minaga; Tomohiro Watanabe; Yasuyuki Arai; Masahiro Shiokawa; Akane Hara; Tomoe Yoshikawa; Ken Kamata; Kouhei Yamashita; Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2020-01-20       Impact factor: 7.527

6.  Case Report: A Case of Intestinal Behçet's Disease Exhibiting Enhanced Expression of IL-6 and Forkhead Box P3 mRNA After Treatment With Infliximab.

Authors:  Keisuke Yoshikawa; Tomohiro Watanabe; Ikue Sekai; Ryutaro Takada; Akane Hara; Masayuki Kurimoto; Yasuhiro Masuta; Yasuo Otsuka; Tomoe Yoshikawa; Sho Masaki; Ken Kamata; Kosuke Minaga; Yoriaki Komeda; Takaaki Chikugo; Masatoshi Kudo
Journal:  Front Med (Lausanne)       Date:  2021-05-14

Review 7.  Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?

Authors:  Masataka Yokode; Masahiro Shiokawa; Yuzo Kodama
Journal:  Diagnostics (Basel)       Date:  2021-04-25

Review 8.  Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders.

Authors:  D Pagliari; A Saviano; E E Newton; M L Serricchio; A A Dal Lago; A Gasbarrini; R Cianci
Journal:  Mediators Inflamm       Date:  2018-02-01       Impact factor: 4.711

9.  Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.

Authors:  Akane Hara; Tomohiro Watanabe; Kosuke Minaga; Tomoe Yoshikawa; Ken Kamata; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

Review 10.  Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations.

Authors:  Dimitri Poddighe
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.